Genepharm SA Information

Genepharm, since 1971, investing in high quality and having people as its absolute priority, has established its presence both in the Greek and international drug market, through the development, production and distribution of certified generic pharmaceutical products in more than 90 countries. In its privately owned plant, with an area of 15,000 m2, in Pallini, Attica, it houses two separate advanced production lines, designed according to all European specifications (EU GMPs). Each one specializes in the production of one of two categories of formulations: conventional and oncological solids. With high expertise in both conventional product forms and advanced technology ones, Genepharm offers solutions in a wide range of therapeutic categories, such as e.g. cardiology, diabetes, oncology, urology, antipsychotic preparations, etc. Its production capacity reaches 500 million tablets and 40 million capsules in solid conventional and 140 million tablets and 10 million capsules in solid oncology.